Connect with us

Hi, what are you looking for?

Stock

(Reuters) – China’s medical regulator has approved Eli Lilly (NYSE:LLY)’s treatment for early Alzheimer’s, providing patients with another option after Eisai and Biogen (NASDAQ:BIIB)’s...

Stock

Investing.com– Australia’s Insignia Financial has rejected a A$2.67 billion ($1.69 billion) takeover bid from Bain Capital, saying the offer does not provide fair value to...

Stock

By David Shepardson WASHINGTON (Reuters) -The U.S. Transportation Department on Tuesday finalized its awards of five new daily round-trip flights from Washington Reagan National...

Stock

Investing.com– Eli Lilly and Company (NYSE:LLY) said on Tuesday evening that China’s food and drug regulator had approved its Kisunla treatment for early symptomatic Alzheimer’s...

Stock

By Giuseppe Fonte and Giulio Piovaccari ROME (Reuters) -Fiat-maker Stellantis (NYSE:STLA) on Tuesday presented an upbeat plan to revitalise its output in Italy, aimed...

Stock

Investing.com– Shares of Nissan) and Mitsubishi Motors)rose sharply on Wednesday after media reports said Honda  and Nissan (OTC:NSANY) were considering a three-way merger in...

Stock

Investing.com –BofA Securities upgraded Ambarella Inc (NASDAQ:AMBA) to “neutral” from “underperform,” with the price target raised to $80 from $65, on expected growth acceleration....

Stock

Monday’s market has seen significant movements in various stocks, with mega-cap names like Avago Technologies (NASDAQ:AVGO) and Tesla Motors (NASDAQ:TSLA) experiencing substantial intra-day stock...

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Disclaimer: beneficialinvestmentnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 beneficialinvestmentnow.com